CVR number 42174238
Industry 86.2200 Specialist medical practice activities

Orthocare1 ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2019
N/A
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Bankruptcy risk for industry  0.7% 0.7% 0.7% 0.7% 0.7%  
Bankruptcy risk  0.0% 11.8% 10.6% 7.8% 7.9%  
Credit score (0-100)  0 20 22 31 30  
Credit rating  N/A BB BB BB BB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
N/A
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales  0 0 0 0 0  
Gross profit  0.0 166 532 320 281  
EBITDA  0.0 166 532 285 272  
EBIT  0.0 166 532 285 272  
Pre-tax profit (PTP)  0.0 165.9 517.8 281.0 267.6  
Net earnings  0.0 129.4 403.9 219.2 208.7  
Pre-tax profit without non-rec. items  0.0 166 518 281 268  
 
See the entire income statement

Balance sheet (kDKK) 
2019
N/A
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  0.0 169 573 792 1,001  
Interest-bearing liabilities  0.0 0.0 1,261 1,261 1,261  
Balance sheet total (assets)  0.0 213 2,012 2,262 2,333  
Net Debt  0.0 -174 -752 -1,001 -1,073  
 
See the entire balance sheet

Volume 
2019
N/A
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 166 532 320 281  
Gross profit growth  0.0% 0.0% 220.4% -39.8% -12.2%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 213 2,012 2,262 2,333  
Balance sheet change%  0.0% 0.0% 844.3% 12.4% 3.2%  
Added value  0.0 166.1 532.1 285.0 272.1  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 1.0 2.0 3.0 4.0  

Profitability 
2019
N/A
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 100.0% 100.0% 89.0% 96.8%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 77.9% 47.8% 13.3% 11.8%  
ROI %  0.0% 98.0% 53.1% 14.7% 12.6%  
ROE %  0.0% 76.4% 108.8% 32.1% 23.3%  

Solidity 
2019
N/A
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Equity ratio %  0.0% 79.5% 28.5% 35.0% 42.9%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% -104.9% -141.3% -351.3% -394.3%  
Gearing %  0.0% 0.0% 219.9% 159.1% 125.9%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 2.3% 0.3% 0.4%  

Liquidity 
2019
N/A
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Quick Ratio  0.0 29.7 1.6 1.8 1.9  
Current Ratio  0.0 29.7 1.6 1.8 1.9  
Cash and cash equivalent  0.0 174.1 2,012.4 2,261.7 2,333.1  

Capital use efficiency 
2019
N/A
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 205.9 723.7 1,001.1 1,072.6  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
N/A
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0